Axicabtagene ciloleucel for large B-cell lymphoma: Health technology assessment introduction and clinical review protocol
Lymphomas are blood cancers that develop in the lymphatic system and are divided into Hodgkin lymphoma and non-Hodgkin lymphomas (NHL). NHLs are categorized as B-cell, Tcell, or natural killer/T-cell lymphoma, depending on the cell implicated in the disease. While B-cell NHLs display a wide range of...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
May 2019, 2019
|
| Series: | CADTH optimal use report
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references